Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Identification of a Universal Group B Streptococcus Vaccine by Multiple Genome Screen
Domenico Maione,1*Immaculada Margarit,1*Cira D. Rinaudo,1Vega Masignani,1Marirosa Mora,1Maria Scarselli,1Hervé Tettelin,2Cecilia Brettoni,1Emilia T. Iacobini,1Roberto Rosini,1Nunzio D'Agostino,1Lisa Miorin,1Scilla Buccato,1Massimo Mariani,1Giuliano Galli,1Renzo Nogarotto,1Vincenzo Nardi Dei,1Filipo Vegni,1Claire Fraser,2Giuseppe Mancuso,3Giuseppe Teti,3Lawrence C. Madoff,4Lawrence C. Paoletti,4Rino Rappuoli,1Dennis L. Kasper,4John L. Telford,1Guido Grandi1
Group B Streptococcus (GBS) is a multiserotype bacterial pathogenrepresenting a major cause of life-threatening infections innewborns. To develop a broadly protective vaccine, we analyzedthe genome sequences of eight GBS isolates and cloned and tested312 surface proteins as vaccines. Four proteins elicited protectionin mice, and their combination proved highly protective againsta large panel of strains, including all circulating serotypes.Protection also correlated with antigen accessibility on thebacterial surface and with the induction of opsonophagocyticantibodies. Multigenome analysis and screening described hererepresent a powerful strategy for identifying potential vaccinecandidates against highly variable pathogens.
1 Chiron srl, Via Fiorentina 1, 53100 Siena, Italy. 2 Institute for Genome Research, 9712 Medical Center Drive, Rockville, MD 20850, USA. 3 Department of Pathology and Experimental Microbiology, University of Messina Medical School, 98125 Messina, Italy. 4 Channing Laboratory, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02125, USA.
* These authors contributed equally to this work.
To whom correspondence should be addressed. E-mail: guido_grandi{at}chiron.com
The editors suggest the following Related Resources on Science sites:
In Science Magazine
BREVIA
Peter Lauer, Cira D. Rinaudo, Marco Soriani, Immaculada Margarit, Domenico Maione, Roberto Rosini, Anna Rita Taddei, Marirosa Mora, Rino Rappuoli, Guido Grandi, and John L. Telford (1 July 2005) Science309 (5731), 105.
[DOI: 10.1126/science.1111563] |Abstract »|Full Text »|PDF »|Supporting Online Material »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Sortase A Utilizes an Ancillary Protein Anchor for Efficient Cell Wall Anchoring of Pili in Streptococcus agalactiae.
A. H. Nobbs, R. Rosini, C. D. Rinaudo, D. Maione, G. Grandi, and J. L. Telford (2008)
Infect. Immun.
76, 3550-3560
|Abstract »|Full Text »|PDF »
A Second Pilus Type in Streptococcus pneumoniae Is Prevalent in Emerging Serotypes and Mediates Adhesion to Host Cells.
F. Bagnoli, M. Moschioni, C. Donati, V. Dimitrovska, I. Ferlenghi, C. Facciotti, A. Muzzi, F. Giusti, C. Emolo, A. Sinisi, et al. (2008)
J. Bacteriol.
190, 5480-5492
|Abstract »|Full Text »|PDF »
Recombinant Group B Streptococcus Alpha-Like Protein 3 Is an Effective Immunogen and Carrier Protein.
H.-H. Yang, S. J. Mascuch, L. C. Madoff, and L. C. Paoletti (2008)
Clin. Vaccine Immunol.
15, 1035-1041
|Abstract »|Full Text »|PDF »
A group B streptococcal pilus protein promotes phagocyte resistance and systemic virulence.
H. C. Maisey, D. Quach, M. E. Hensler, G. Y. Liu, R. L. Gallo, V. Nizet, and K. S. Doran (2008)
FASEB J
22, 1715-1724
|Abstract »|Full Text »|PDF »
Proteomics Characterization of Outer Membrane Vesicles from the Extraintestinal Pathogenic Escherichia coli {Delta}tolR IHE3034 Mutant.
F. Berlanda Scorza, F. Doro, M. J. Rodriguez-Ortega, M. Stella, S. Liberatori, A. R. Taddei, L. Serino, D. Gomes Moriel, B. Nesta, M. R. Fontana, et al. (2008)
Mol. Cell. Proteomics
7, 473-485
|Abstract »|Full Text »|PDF »
Discovery of a novel class of highly conserved vaccine antigens using genomic scale antigenic fingerprinting of pneumococcus with human antibodies.
C. Giefing, A. L. Meinke, M. Hanner, T. Henics, D. B. Minh, D. Gelbmann, U. Lundberg, B. M. Senn, M. Schunn, A. Habel, et al. (2008)
J. Exp. Med.
205, 117-131
|Abstract »|Full Text »|PDF »
Introduction of Zwitterionic Motifs into Bacterial Polysaccharides Generates TLR2 Agonists Able to Activate APCs.
S. Gallorini, F. Berti, P. Parente, R. Baronio, S. Aprea, U. D'Oro, M. Pizza, J. L. Telford, and A. Wack (2007)
J. Immunol.
179, 8208-8215
|Abstract »|Full Text »|PDF »
Analysis of Group B Streptococcal Isolates from Infants and Pregnant Women in Portugal Revealing Two Lineages with Enhanced Invasiveness.
E. R. Martins, M. A. Pessanha, M. Ramirez, J. Melo-Cristino, and and the Portuguese Group for the Study of Streptoc (2007)
J. Clin. Microbiol.
45, 3224-3229
|Abstract »|Full Text »|PDF »
Serotype IX, a Proposed New Streptococcus agalactiae Serotype.
H.-C. Slotved, F. Kong, L. Lambertsen, S. Sauer, and G. L. Gilbert (2007)
J. Clin. Microbiol.
45, 2929-2936
|Abstract »|Full Text »|PDF »
Identification of Candidates for a Subunit Vaccine against Extraintestinal Pathogenic Escherichia coli.
L. Durant, A. Metais, C. Soulama-Mouze, J.-M. Genevard, X. Nassif, and S. Escaich (2007)
Infect. Immun.
75, 1916-1925
|Abstract »|Full Text »|PDF »
Transcriptional and Proteomic Profiles of Group B Streptococcus Type V Reveal Potential Adherence Proteins Associated with High-Level Invasion.
A. K. Johri, I. Margarit, M. Broenstrup, C. Brettoni, L. Hua, S. P. Gygi, J. L. Telford, G. Grandi, and L. C. Paoletti (2007)
Infect. Immun.
75, 1473-1483
|Abstract »|Full Text »|PDF »
Group B Streptococcal Pilus Proteins Contribute to Adherence to and Invasion of Brain Microvascular Endothelial Cells.
H. C. Maisey, M. Hensler, V. Nizet, and K. S. Doran (2007)
J. Bacteriol.
189, 1464-1467
|Abstract »|Full Text »|PDF »
Streptococcus pneumoniae Pilus Subunits Protect Mice against Lethal Challenge.
C. Gianfaldoni, S. Censini, M. Hilleringmann, M. Moschioni, C. Facciotti, W. Pansegrau, V. Masignani, A. Covacci, R. Rappuoli, M. A. Barocchi, et al. (2007)
Infect. Immun.
75, 1059-1062
|Abstract »|Full Text »|PDF »
Vaccine assembly from surface proteins of Staphylococcus aureus.
Y. K. Stranger-Jones, T. Bae, and O. Schneewind (2006)
PNAS
103, 16942-16947
|Abstract »|Full Text »|PDF »
Inaugural Article: A universal vaccine for serogroup B meningococcus.
M. M. Giuliani, J. Adu-Bobie, M. Comanducci, B. Arico, S. Savino, L. Santini, B. Brunelli, S. Bambini, A. Biolchi, B. Capecchi, et al. (2006)
PNAS
103, 10834-10839
|Abstract »|Full Text »|PDF »
Search for Bacillus anthracis Potential Vaccine Candidates by a Functional Genomic-Serologic Screen.
O. Gat, H. Grosfeld, N. Ariel, I. Inbar, G. Zaide, Y. Broder, A. Zvi, T. Chitlaru, Z. Altboum, D. Stein, et al. (2006)
Infect. Immun.
74, 3987-4001
|Abstract »|Full Text »|PDF »
Molecular characterization of nontypeable group B streptococcus..
S. V. Ramaswamy, P. Ferrieri, A. E. Flores, and L. C. Paoletti (2006)
J. Clin. Microbiol.
44, 2398-2403
|Abstract »|Full Text »|PDF »
Interaction of neonatal phagocytes with group B streptococcus: recognition and response..
P. Henneke and R. Berner (2006)
Infect. Immun.
74, 3085-3095
|Full Text »|PDF »
Identification of novel cps locus polymorphisms in nontypable group B Streptococcus.
S. V. Ramaswamy, P. Ferrieri, L. C. Madoff, A. E. Flores, N. Kumar, H. Tettelin, and L. C. Paoletti (2006)
J. Med. Microbiol.
55, 775-783
|Abstract »|Full Text »|PDF »
A unique serine-rich repeat protein (Srr-2) and novel surface antigen ({varepsilon}) associated with a virulent lineage of serotype III Streptococcus agalactiae..
K. N. Seifert, E. E. Adderson, A. A. Whiting, J. F. Bohnsack, P. J. Crowley, and L. J. Brady (2006)
Microbiology
152, 1029-1040
|Abstract »|Full Text »|PDF »
Sortases and the Art of Anchoring Proteins to the Envelopes of Gram-Positive Bacteria.
L. A. Marraffini, A. C. DeDent, and O. Schneewind (2006)
Microbiol. Mol. Biol. Rev.
70, 192-221
|Abstract »|Full Text »|PDF »
Toward a Genome-Wide Systems Biology Analysis of Host-Pathogen Interactions in Group A Streptococcus.
Group A Streptococcus produce pilus-like structures containing protective antigens and Lancefield T antigens.
M. Mora, G. Bensi, S. Capo, F. Falugi, C. Zingaretti, A. G. O. Manetti, T. Maggi, A. R. Taddei, G. Grandi, and J. L. Telford (2005)
PNAS
102, 15641-15646
|Abstract »|Full Text »|PDF »
Genome analysis of multiple pathogenic isolates of Streptococcus agalactiae: Implications for the microbial "pan-genome".
H. Tettelin, V. Masignani, M. J. Cieslewicz, C. Donati, D. Medini, N. L. Ward, S. V. Angiuoli, J. Crabtree, A. L. Jones, A. S. Durkin, et al. (2005)
PNAS
102, 13950-13955
|Abstract »|Full Text »|PDF »
Genome Analysis Reveals Pili in Group B Streptococcus.
P. Lauer, C. D. Rinaudo, M. Soriani, I. Margarit, D. Maione, R. Rosini, A. R. Taddei, M. Mora, R. Rappuoli, G. Grandi, et al. (2005)
Science
309, 105
|Abstract »|Full Text »|PDF »